当前位置: X-MOL 学术medRxiv. Neurol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Developing and Validating a New Web-Based Tapping Test for Measuring Distal Bradykinesia in Parkinson's Disease
medRxiv - Neurology Pub Date : 2020-07-01 , DOI: 10.1101/2020.06.30.20141572
Noreen Akram , Haoxuan Li , Aaron Ben-Joseph , Caroline Budu , David Gallagher , Jonathan P Bestwick , Alastair J Noyce , Cristina Simonet

Background: Disability in Parkinson′s disease (PD) is measured by standardised scales including the MDS-UPDRS, which are subject to high inter and intra-rater variability and fail to capture subtle motor impairment. The BRadykinesia Akinesia INcoordination (BRAIN) test is a previously validated keyboard tapping test, evaluating proximal upper-limb motor impairment. Here, a new Distal Bradykinesia Tapping (DBT) test was developed to assess distal upper-limb function. Kinetic parameters of the test include kinesia score (KS20, key taps over 20 seconds), akinesia time (AT20, mean dwell-time on each key) and incoordination score (IS20, variance of travelling time between key taps). Objective: To develop and validate a new keyboard-tapping test to assess distal motor function in PD patients. Methods: The DBT test was validated in 45 PD patients and 24 controls, alongside the BRAIN test. Test scores were compared between groups and correlated with MDS-UPDRS-III scores. 10 additional PD patients were recruited to assess the DBT test in monitoring motor fluctuations. Results: All three parameters discriminated between patients and controls, with KS20 performing best, yielding 75% sensitivity for 85% specificity; area under the receiver operating characteristic curve (AUC) = 0.87. Combination of both the DBT and BRAIN tests improved discrimination (AUC=0.91). KS20 and AT20 correlated with MDS-UPDRS-III (Pearson′s r=-0.49, p<0.001 and r=0.54, p<0.001, respectively). The DBT test detected subtle changes in motor fluctuation states, which were not reflected clearly by MDS-UPDRS-III sub-scores. Conclusion: The DBT test is a user-friendly method of assessing distal motor dysfunction in PD, possibly permitting longitudinal monitoring of PD motor complications.

中文翻译:

开发和验证一种新的基于Web的轻拍测试,以测量帕金森氏病的远端运动迟缓

背景:帕金森氏病(PD)的残疾是通过包括MDS-UPDRS在内的标准化量表来衡量的,该量表存在较高的评分者间和评分者内变异性,无法捕获微妙的运动障碍。慢肌运动障碍运动(BRAIN)测试是先前经过验证的键盘敲击测试,用于评估近端上肢运动障碍。在这里,开发了一种新的远端运动迟缓拍击(DBT)测试,以评估远端上肢功能。测试的动力学参数包括运动学评分(KS20,超过20秒的击键),运动障碍时间(AT20,每个键的平均停留时间)和不协调得分(IS20,击键之间的行程时间变化)。目的:开发并验证一种新的键盘敲击测试,以评估PD患者的远端运动功能。方法:除45例PD患者和24例对照外,DBT检验已通过BRAIN检验。比较各组之间的考试成绩,并将其与MDS-UPDRS-III成绩相关。招募了另外10名PD患者以评估DBT测试以监测运动波动。结果:区分患者和对照组的所有三个参数,KS20表现最佳,灵敏度为75%,特异性为85%。接收器工作特性曲线(AUC)下的面积= 0.87。DBT和BRAIN测试的组合可提高分辨力(AUC = 0.91)。KS20和AT20与MDS-UPDRS-III相关(Pearson'sr = -0.49,p <0.001和r = 0.54,p <0.001)。DBT测试检测到电动机波动状态的细微变化,而MDS-UPDRS-III子分数并未清楚反映。结论:
更新日期:2020-07-01
down
wechat
bug